Suspended

MTMPharmacist-Led Discharge Counseling and Medication Therapy Management for Heart Failure Patients

0 criteria met from your profileSee at a glance how your profile meets each eligibility criteria.
Study Aim

This study aims to reduce hospital readmissions for heart failure patients by providing pharmacist-led discharge counseling and medication therapy management, comparing the results with a similar group from a 2011 patient list.

What is being tested

Discharge medication counseling from a pharmacist

+ Home medication if needed

+ Follow-up visit at Medication Therapy Management clinic

Other
Who is being recruted

Cardiovascular Diseases

+ Heart Diseases

+ Heart Failure

Over 18 Years
See all eligibility criteria
How is the trial designed

Supportive Care Study

Interventional
Study Start: January 2013
See protocol details

Summary

Principal SponsorProvidence Health & Services
Last updated: May 22, 2013
Sourced from a government-validated database.Claim as a partner

Study start date: January 1, 2013

Actual date on which the first participant was enrolled.

The active arm of this study (medication related hospital discharge counseling by a pharmacist, home medications, and 7 day follow-up visit at a pharmacist run MTM clinic) is available to all subjects. To study the primary goal of reducing the 30 day readmission rate the data obtained from the active arm subjects will be compared to a match group of hospitalized patients that were previously discharged with a diagnosis of heart failure. The data for all secondary study goals will be obtained directly from the active arm subjects.

NCT01822171
Principal SponsorProvidence Health & Services
Last updated: May 22, 2013
Sourced from a government-validated database.Claim as a partner

Protocol

This section provides details of the study plan, including how the study is designed and what the study is measuring.
Design Details

1 patient to be enrolled

Total number of participants that the clinical trial aims to recruit.

Supportive Care Study

These studies explore ways to improve comfort and daily life for people living with a condition. They may focus on easing symptoms, reducing treatment side effects, or supporting overall well-being.

Eligibility

Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.
Conditions
Criteria

Any sex

Biological sex of participants that are eligible to enroll.

Over 18 Years

Range of ages for which participants are eligible to join.

Healthy volunteers not allowed

If individuals who are healthy and do not have the condition being studied can participate.

Conditions

Pathology

Cardiovascular DiseasesHeart DiseasesHeart Failure

Criteria

Inclusion Criteria: Heart Failure with high risk for readmission. Enroll in study prior to hospital discharge. Exclusion Criteria: -

Study Plan

Find out more about all the medication administered in this study, their detailed description and what they involve.
Treatment Groups
Study Objectives

One single intervention group is designated in this study

This study does not include a placebo group 

Treatment Groups

Group I

Experimental
At the time of hospital discharge the subject will receive: Discharge medication counseling from a pharmacist Home medication if needed Approximately 7 days after hospital discharge the subject have a Follow-up visit at Medication Therapy Management clinic.

Study Objectives

Primary Objectives

Secondary Objectives

Study Centers

These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.

This study has 2 locations

Providence Centralia Hospital

Centralia, United StatesOpen Providence Centralia Hospital in Google Maps

Providence St. Peter Hospital

Olympia, United States
Suspended2 Study Centers